Navigation Links
Clinical Trial Results Suggest Long-Term Treatment Benefit of,Tetrabenazine for Chorea Associated with Huntington's Disease

BOSTON--(BUSINESS WIRE)--May 3, 2007 - New data show the investigational drug tetrabenazine maintained reduction of chorea associated with Huntington's disease (HD) up to 80 weeks in those patients who successfully completed treatment in a 13-week trial. These data suggest that tetrabenazine can be used successfully to sustain reduced chorea burden in long-term use.

"These findings demonstrate the potential benefit of tetrabenazine as maintenance therapy for U.S. patients who present with troublesome chorea," said Dr. Samuel Frank, Assistant Professor of Neurology at Boston University Medical Center, who presented the data on behalf of the Huntington Study Group. "Following individualized patient dosing based upon response and side effects, we were able to maintain reduced chorea burden."

Tetrabenazine is designed to reversibly stop the release of dopamine, a brain chemical involved in abnormal movements such as chorea. Chorea can be a debilitating feature of a number of neurological diseases, characterized by excessive, involuntary and repetitive movements that may flow from one body part to another. The movements may involve the face, limbs or the entire body. HD is one of the more notable diseases with chorea that may at first be limited to the fingers and toes. However, as the disease advances, the abnormal movements become more widespread.

Study Design and Results

This study was an open-label study for patients who successfully completed treatment in a 13-week double-blind, placebo-controlled Phase III trial. In all, 75 eligible patients enrolled in the 80-week study and were given tetrabenazine in tablet form, which was gradually increased in dose to the best individualized maintenance dose based on each research participant's response and side effects.

Forty-five of the original 75 patients completed 80 weeks of the open-label study. At week 80, disease symptoms as measured by
'"/>




Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:10/30/2014)... 29, 2014  BioMed Realty Trust, Inc. (NYSE: ... focusing on life sciences, today announced financial results ... Third Quarter 2014 Highlights Financial and ... transactions during the quarter representing approximately 657,700 square ... the third quarter of approximately 219,700 square feet; ...
(Date:10/27/2014)... MENLO PARK, Calif. , Oct. 27, 2014 /PRNewswire/ ... isolation of blood flow and delivery of fluids to ... the RenovoRx Board of Directors has appointed Shaun ... additional Member of the RenovoRx Board of Directors. Bagai ... medical technology industry. Bagai joined RenovoRx in ...
(Date:10/27/2014)... , Oct. 27, 2014 Research and Markets ... Vaccines Market 2014-2018" report to their offering. ... caused by a variant of the swine H1N1 virus, known ... which infects nose, throat, and lungs. H1N1 virus is an ... infect different animal species such as humans, swine, birds, seals, ...
Breaking Medicine Technology:BioMed Realty Trust Reports Third Quarter 2014 Financial Results 2BioMed Realty Trust Reports Third Quarter 2014 Financial Results 3BioMed Realty Trust Reports Third Quarter 2014 Financial Results 4BioMed Realty Trust Reports Third Quarter 2014 Financial Results 5BioMed Realty Trust Reports Third Quarter 2014 Financial Results 6BioMed Realty Trust Reports Third Quarter 2014 Financial Results 7BioMed Realty Trust Reports Third Quarter 2014 Financial Results 8BioMed Realty Trust Reports Third Quarter 2014 Financial Results 9BioMed Realty Trust Reports Third Quarter 2014 Financial Results 10BioMed Realty Trust Reports Third Quarter 2014 Financial Results 11BioMed Realty Trust Reports Third Quarter 2014 Financial Results 12BioMed Realty Trust Reports Third Quarter 2014 Financial Results 13BioMed Realty Trust Reports Third Quarter 2014 Financial Results 14BioMed Realty Trust Reports Third Quarter 2014 Financial Results 15BioMed Realty Trust Reports Third Quarter 2014 Financial Results 16BioMed Realty Trust Reports Third Quarter 2014 Financial Results 17BioMed Realty Trust Reports Third Quarter 2014 Financial Results 18BioMed Realty Trust Reports Third Quarter 2014 Financial Results 19BioMed Realty Trust Reports Third Quarter 2014 Financial Results 20BioMed Realty Trust Reports Third Quarter 2014 Financial Results 21RenovoRx Board Names Shaun R. Bagai as CEO 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 3
... Digital Assent, provider of the award-winning PatientPad® self-service ... that it has appointed Frank Garland as vice president ... Garland will focus on increasing the digital advertising and ... the company,s New York sales office. "Frank ...
... Oct. 20, 2011 Bend Research Inc. ( www.bendresearch.com ... has announced that John McLeod has joined the company ... http://photos.prnewswire.com/prnh/20111020/CL87178 ) McLeod was formerly Director ... six years, where his strategic vision is credited with ...
Cached Medicine Technology:Digital Assent Names Frank Garland Vice President of Advertising Sales 2Bend Research Announces New Chief Financial Officer 2
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, 2014 ... of three West African nations ravaged by the disease -- ... Dr. Bruce Aylward, WHO,s assistant director general, said there,s been ... no increase in laboratory-confirmed cases. He said he was cautiously ... be making some progress, The New York Times ...
(Date:10/30/2014)... October 30, 2014 Global prebiotics market ... according to a new study by Grand View Research, ... demand for sugar and fat free products owing to ... demand for prebiotics over the forecast period. , View ... , Food & beverage was the largest application segment ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 The annual ... (NAMS) came to a close on Saturday, October 18th, ... the Society’s inception in 1989. NAMS is North America’s ... quality of life of all women during midlife and ... With over 2,000 physicians and thought leaders from fields ...
(Date:10/30/2014)... who used stem cells to create miniature human stomachs ... new way to learn more about the development and ... pluripotent stem cells -- which can become any type ... functional miniature stomachs, to study infection by H. ... stomach cancer. The miniature stomachs offer many research ...
(Date:10/30/2014)... a low-carb, high-fat diet could help control epilepsy that ... A review of five studies found that a ... like bacon, eggs, heavy cream, butter, fish and green ... doesn,t improve with medication. "We need new treatments ... seizures are not stopped by medications," study co-author Dr. ...
Breaking Medicine News(10 mins):Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
... Senior,Services has expanded into the San Joaquin County, California ... Response Company, is proud to announce seniors in San ... Services for outstanding,care. For over a decade, a caring ... sincere concern for the betterment of life that goes ...
... Donor Centers, LENEXA, Kan., Oct. 31 ... provider of ClosedLoop(TM) clinical,systems for blood and medication ... of substantially all of the assets of Integrated,Marketing ... products and,services that enable blood and plasma donation ...
... (NYSE: BSX ) announced today that a jury ... Boston Scientific infringes a patent of,Cordis Corporation, a subsidiary ... Company said it believes the finding of infringement is,in ... overturn it. No damages were determined because the ...
... MEMPHIS, Tenn., Oct. 31 Mrs. Vivian,Berryhill will ... Global Summit,on AIDS and the Church, at Saddleback ... president of the National Coalition of Pastors,Spouses (NCPS), ... whose mission is to raise health awareness in,communities ...
... chiropractic,and five friends of chiropractic were honored with ... State Convention on,October 21, 2007 at the Doubletree ... their chiropractic colleagues and peers., In recognition ... profession in Colorado, the following individuals received,these prestigious ...
... the scientific journal Genome Research ( www.genome.org ) ... domestic cat genome ( Felis catus ). , ... well-documented lineage can be traced back several generations to Sweden, ... that are currently being analyzed using light (two-fold) genome sequence ...
Cached Medicine News:Health News:Announcing Always Best Care Senior Services Expansion Into San Joaquin County, California 2Health News:Mediware Completes Acquisition of Integrated Marketing Solutions 2Health News:Mediware Completes Acquisition of Integrated Marketing Solutions 3Health News:Boston Scientific Announces Verdict in Cordis Litigation 2Health News:Boston Scientific Announces Verdict in Cordis Litigation 3Health News:Head of Pastors' Spouses to Challenge Women at Saddleback's Global Summit on AIDS and the Church 2Health News:Colorado Doctors of Chiropractic Win Awards 2Health News:Domestic cat genome sequenced 2
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... lightweight brace is designed for the ... fractures. The anatomically correct design achieves ... for optimal control of ulnar segments. ... motion is permitted to prevent problems ...
Finger /Thumb Splint has a stay that may be shaped to hold finger or thumb in exact degree of flexion. It also has a contact closure....
... joint or DIP joint flexioncontractures of any degree. ... gel-lining cushions injured fingers so treatment to straighten ... more successful therapy results. Use during the day ... maintain gains in motion. Available in small, medium ...
Medicine Products: